Trademark: LYTENAVA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for LYTENAVA
We do not have any records of a proof of use for LYTENAVA at this moment.
Possible trademark infringements of LYTENAVA
Basic Information about LYTENAVA
- Serial Number
- 88872045
- Filing Date
- 14 Apr 2020
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of LYTENAVA on the blockchain with WikiTrademarks.io.
- First use of LYTENAVA anywhere
- LYTENAVA was first used on 29 Aug 2022 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns LYTENAVA?
1. Outlook Therapeutics, Inc. Iselin NJ
2. Outlook Therapeutics, Inc. Cranbury NJ
Correspondent
- Ariana G. Hiscott COOLEY LLP
- 1299 PENNSYLVANIA AVENUE, NW, SUITE 700
- WASHINGTON, DC 20004-2400
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io